Previous reports from Japanese researchers provided convincing data, which show that autoantibodies against p53 and NY-ESO-1 are useful biomarkers in the early diagnosis of ESCC and gastric cancer [40–42]. The gene discussed is TP53; the disease is gastric cancer.